Alcala Andalucia Ansermanuevo Argelia

Alcala Andalucia Ansermanuevo Argelia

INMUNOPREVENIBLES MENINGITIS BACTERIANA AGUDA AGENTES MUNICIPIO DE DIFTERIA RESIDENCIA* O BACTERIANO EN GENERAL PROCEDENCIA** ACUMULADO ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO 2019 ALCALA 0 0 0 0 0 0 ANDALUCIA 0 0 0 0 0 0 ANSERMANUEVO 0 0 0 0 0 0 ARGELIA 0 0 0 0 0 0 BOLIVAR 0 0 0 0 0 0 BUGA 0 0 0 0 0 0 BUGALAGRANDE 0 0 0 0 0 0 CAICEDONIA 0 0 0 1 0 0 CALI 0 1 0 108 5 4 CANDELARIA 0 0 0 0 0 0 CARTAGO 0 0 0 1 0 0 DAGUA 1 0 0 0 0 0 DARIEN 0 0 0 1 0 0 EL AGUILA 0 0 0 0 0 0 EL CAIRO 0 0 0 2 0 0 EL CERRITO 0 0 0 1 0 0 EL DOVIO 0 0 0 0 0 0 FLORIDA 1 0 0 3 0 0 GINEBRA 0 0 0 0 0 0 GUACARI 0 0 0 2 0 0 JAMUNDI 0 0 0 6 0 0 LA CUMBRE 0 0 0 0 0 0 LA UNION 0 0 0 0 0 0 LA VICTORIA 0 0 0 1 0 0 OBANDO 0 0 0 0 0 0 PALMIRA 1 0 0 9 0 1 PRADERA 0 0 0 2 0 0 RESTREPO 0 0 0 0 0 0 RIOFRIO 0 0 0 0 0 0 ROLDANILLO 0 0 0 1 0 0 SAN PEDRO 0 0 0 0 0 0 SEVILLA 0 0 0 0 0 0 TORO 0 0 0 0 0 0 TRUJILLO 0 0 0 0 0 0 TULUA 0 0 0 6 0 0 ULLOA 0 0 0 0 0 0 VERSALLES 0 0 0 0 0 0 VIJES 0 0 0 0 0 0 YOTOCO 0 0 0 1 0 1 YUMBO 0 0 0 3 0 0 ZARZAL 0 0 0 1 0 0 TOTAL 3 2 0 149 7 6 TABLERO DE MANDO SEMANA 46 INMUNOPREVENIBLES PARALISIS FLACIDA AGUDA PAROTIDITIS RUBEOLA ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 0 0 0 1 3 0 0 0 0 0 3 1 0 0 0 0 0 1 2 0 0 0 0 0 0 2 0 0 0 0 0 0 3 0 0 0 0 0 14 23 1 0 0 0 0 3 3 0 0 0 0 0 1 2 0 0 7 3 0 404 414 2 2 1 0 0 1 9 0 0 0 0 0 13 17 1 1 0 0 0 2 6 0 0 0 0 0 2 6 0 0 0 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 1 4 0 0 0 0 0 0 2 0 0 0 0 0 6 19 1 0 0 0 0 0 10 0 0 0 0 0 0 4 0 0 1 0 0 20 10 0 0 0 0 0 5 1 0 0 0 0 0 4 5 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 1 0 0 19 44 0 1 0 0 0 0 10 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 6 0 0 0 0 0 1 2 0 0 0 0 0 0 3 0 0 0 0 0 1 3 0 0 0 0 0 0 4 0 0 0 0 0 42 25 1 1 0 0 0 0 3 0 0 0 0 0 1 1 0 0 0 0 0 0 2 0 0 0 0 0 2 2 0 0 3 0 0 11 15 0 0 0 0 0 11 8 0 0 13 5 0 574 678 6 5 TABLERO DE MANDO SEMANA 46 INMUNOPREVENIBLES RUBEOLA SARAMPION SINDROME DE RUBEOLA CONGENITA ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 16 19 0 1 2 0 0 0 1 0 0 0 1 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 12 0 29 28 0 4 3 INMUNOPREVENIBLES SINDROME DE RUBEOLA CONGENITA TETANOS ACCIDENTAL TETANOS NEONATAL OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 1 0 INMUNOPREVENIBLES TOSFERINA VARICELA INDIVIDUAL EVENTO ADVERSO SEGUIDO A LA VACUNACION. ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 1 0 0 11 2 0 0 0 0 0 8 1 0 0 0 0 0 20 2 0 0 0 0 0 2 2 0 0 0 0 0 34 3 0 0 5 0 0 161 24 3 1 0 0 0 21 3 0 0 0 0 0 31 2 2 2 83 17 1 3089 413 48 34 3 0 0 65 9 0 0 0 0 0 85 18 1 3 0 0 0 34 5 0 1 0 0 0 20 6 1 0 0 0 0 9 1 0 0 0 0 0 85 1 5 0 0 0 0 46 3 0 0 0 0 0 11 31 0 0 1 0 0 128 20 6 1 1 0 0 22 10 0 0 3 0 0 21 4 1 1 3 0 0 133 8 1 0 0 0 0 17 1 0 0 0 0 0 42 4 1 0 0 0 0 11 0 1 0 0 0 0 6 31 0 0 3 0 0 360 44 3 4 0 0 0 30 11 0 0 0 0 0 6 31 0 0 0 0 0 14 0 0 2 0 0 0 40 6 0 0 0 0 0 23 2 1 1 1 0 0 17 4 0 0 0 0 0 9 3 0 0 0 0 0 31 4 0 0 0 0 0 105 24 1 1 0 0 0 3 3 0 0 0 0 0 14 1 0 0 2 0 1 3 31 0 0 0 0 0 16 2 0 0 4 0 0 112 14 4 0 0 0 0 36 5 2 0 110 20 2 4931 680 81 51 INMUNOPREVENIBLES MICOBACTERIAS EVENTO ADVERSO SEGUIDO A LA VACUNACION. VARICELA BROTES LEPRA ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 9 0 3 26 17 0 0 1 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 2 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 7 0 0 8 4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 7 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 1 0 0 1 0 0 1 0 3 0 38 0 5 47 37 MICOBACTERIAS LEPRA TUBERCULOSIS FÁRMACORRESISTENTE TUBERCULOSIS TODAS LAS FORMAS SENSIBLE OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO 0 0 0 0 11 7 0 0 0 0 0 1 3 0 0 0 0 0 5 7 0 0 0 0 0 2 0 0 0 0 0 0 1 2 0 0 0 1 0 49 39 0 0 0 0 0 2 4 0 0 1 0 0 14 12 1 0 38 37 0 1054 990 9 0 2 0 0 8 15 0 0 3 1 0 57 62 0 0 0 1 0 5 10 0 0 0 0 0 1 2 0 0 0 0 0 0 2 0 0 0 0 0 2 1 0 0 0 0 0 12 10 0 0 0 0 0 0 2 0 0 0 0 0 24 18 1 0 1 0 0 2 3 0 0 0 0 0 3 5 0 0 3 1 0 57 31 1 0 0 0 0 0 2 0 0 0 0 0 2 5 0 0 0 0 0 2 3 0 0 0 0 0 1 1 0 0 3 2 1 157 115 0 0 1 0 0 7 11 0 0 0 0 0 3 2 0 0 0 0 0 4 3 0 0 0 0 0 5 9 0 0 0 0 0 2 2 0 0 0 0 0 5 12 0 0 0 0 0 7 3 0 0 0 0 0 2 3 0 0 2 2 0 67 77 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 1 0 0 2 2 0 0 1 0 0 29 23 0 0 0 0 0 9 8 0 0 56 48 1 1615 1518 12 ETV DENGUE DENGUE GRAVE CHIKUNGUÑA ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 27 9 0 0 16 16 1 0 29 13 1 0 5 0 0 0 31 14 5 0 286 392 25 3 47 36 8 0 45 20 4 0 9193 2657 429 26 236 24 16 0 360 214 6 0 83 13 2 0 6 11 1 0 5 1 2 0 3 2 0 0 92 11 5 0 3 2 1 0 210 250 7 0 29 6 3 0 70 27 3 0 133 53 8 0 1 2 0 0 59 11 2 1 15 8 2 0 8 4 1 0 622 342 41 3 69 13 9 1 13 6 1 0 23 38 4 0 24 26 1 0 16 13 12 2 21 9 3 0 5 0 0 0 18 29 1 0 244 338 25 2 0 11 0 0 3 1 0 0 7 5 1 0 54 29 3 0 192 115 7 4 47 46 4 1 0 13309 4817 0 141 43 0 ETV CHIKUNGUÑA ZIKA LEISHMANIASIS CUTANEA ESPERADO OBSERVADO ESPERADO ESPERADO ACUMULADO 2019 OBSERVADO ACUMULADO 2019 ACUMULADO ACUMULADO ACUMULADO 1 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 8 0 0 7 1 0 1 0 0 1 0 0 1 0 0 1 131 27 512 56 0 11 1 0 1 2 0 0 1 2 1 1 0 2 1 0 0 1 0 7 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 1 0 0 0 0 6 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 1 0 0 2 1 4 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 1 4 0 0 0 5 2 9 1 0 3 0 0 2 0 0 1 0 0 0 0 0 0 0 1 0 1 0 1 0 0 1 0 0 0 0 1 0 0 0 0 5 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 6 0 2 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 2 0 2 2 0 0 1 0 2 0 0 0 168 42 550 68 0 0 47 ETV ZOONOSIS LEISHMANIASIS CUTANEA MALARIA ACCIDENTE OFIDICO OBSERVADO ESPERADO OBSERVADO ESPERADO OBSERVADO ACUMULADO 2019 ACUMULADO 2019 ACUMULADO ACUMULADO ACUMULADO ACUMULADO ACUMULADO 0 1 0 0 0 0 0 1 0 1 2 0 0 1 2 0 0 0 0 1 0 0 0 2 3 0 5 0 1 1 0 2 0 0 0 0 1 1 2 0 3 84 22 6 6 0 0 2 0 0 1 12 1 1 0 3 12 3 5 5 0 0 0 2 1 1 0 0 1 1 6 0 0 0 1 0 1 1 0 1 7 1 0 1 0 0 7 1 1 3 0 0 0 2 2 0 0 1 0 1 1 5 0 1 5 0 0 0 0 2 0 0 0 1 0 0 0 0 0 0 0 0 0 2 1 0 12 2 2 6 0 3 2 0 0 0 0 0 1 4 0 0 0 2 0 0 0 0 1 0 0 1 0 0 0 1 2 8 3 0 0 1 0 0 0 0 0 1 3 4 0 15 4 2 1 0 0 0 1 0 1 0 0 1 0 0 0 0 1 1 1 1 0 0 0 0 5 0 2 2 0 2 0 0 0 27 194 50 0 49 55 ZOONOSIS ITS AGRESIONES POR ANIMALES POTENCIALMENTE LEPTOSPIROSIS TRANSMISORES DE RABIA HEPATITIS B,C COINFECCION B-D GRADA DE LA RABIA HUMANA ESPERADO OBSERVADO ESPERADO OBSERVADO ACUMULADO 2019 ACUMULADO 2019 ACUMULADO 2019 ACUMULADO ACUMULADO ACUMULADO ACUMULADO 4 6 82 80 1 3 2 69 97 1 1 0 64 61 2 0 0 22 26 0 1 1 56 66 0 14 75 302 403 3 5 1 83 115 1 3 0 158 184 2 131 57 4098 5174 245 2 1 174 188 5 10 5 321 450 6 4 4 197 219 4 1 5 79 93 0 0 0 19 15 0 0 0 24 23 0 3 2 117 172 1 0 0 33 39 0 4 2 185 232 2 3 2 106 114 0 11 21 107 125 2 5 3 396 528 4 0 0 84 91 0 1 2 110 105 3 0 1 51 61 0 0 0 54 63 2 16 3 769 948 22 2 2 183 156 2 2 4 89 129 1 2 3 54 77 0 1 3 156 150 0 2 3 60 79 0 4 1 184 191 2 1 0 32 64 0 1 1 68 113 1 32 27 385 457 8 0 1 32 27 0 0 0 24 45 1 1 0 46 67 1 5 14 59 70 1 6 8 390 405 7 3 3 149 162 1 0 294 263 0 9477 11864 331 ITS HEPATITIS B,C COINFECCION B-D SIFILIS CONGENITA SIFILIS GESTACIONAL ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 1 0 0 5 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 12 3 28 1 0 415 23 0 0 2 0 0 17 0 1 0 5 0 0 26 1 0 0 0 0 0 4 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 1 0 0 2 0 0 0 2 0 0 2 0 0 0 0 0 0 2 0 0 1 0 0 0 14 1 0 0 0 0 0 1 0 0 0 1 0 0 3 0 0 0 3 0 0 23 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 2 0 0 0 0 0 0 1 0 1 0 7 0 0 46 2 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 2 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 4 0 0 23 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 0 27 1 0 0 4 0 0 5 0 17 5 64 1 1 642 32 ITS ETAS SIFILIS GESTACIONAL VIH/SIDA BROTES DE ETA ** OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO ACUMULADO 2019 ESPERADO OBSERVADO 0 6 0 0 0 0 0 0 3 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 1 1 0 0 0 0 7 0 0 1 0 0 0 13 0 0 0 0 0 10 1515 13 17 82 4 0 1 34 0 0 1 0 0 0 49 1 2 3 0 0 0 8 0 0 1 0 0 0 6 0 0 1 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 1 0 0 0 2 0 0.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    40 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us